摘要
背景:阿尔茨海默氏痴呆的特征是皮层和皮层下的明显萎缩,导致不同的神经心理学缺陷。根据体细胞标记假设,负责产生体细胞标记的区域可以预测决策的后果,从而优化过程,这些患者将受到影响。 目的:本实验的目的是研究阿尔茨海默型痴呆患者的决策过程,以确定由于该疾病导致的这些过程中的潜在缺陷,除了老化典型的认知障碍之外。此外,我们还希望根据前景价格学习参数确定这些患者的决策特征。 方法:我们评估了30名阿尔茨海默病患者和30名健康受试者的对照组。爱荷华州赌博任务的简短版本被使用。 结果:结果显示,患者的选择不如对照。组间差异是定量和定性的,因为观察到的价格学习决策中认定机制的显着差异。这些结果与神经影像学研究的证据以及遗忘患者的工作一致。 结论:我们的病人决策中的问题可能是由于这种疾病的特征性记忆缺陷,这阻碍了他们建立新的刺激 - 奖励关系,并且由于它们出现的顶叶和颞叶萎缩而消除以前学到的反应。
关键词: 轻度阿尔茨海默痴呆,决策,前景价态学习,体征标记假说,软件推车,记忆力减退。
Current Alzheimer Research
Title:Cognitive Mechanisms in Decision-Making in Patients With Mild Alzheimer Disease
Volume: 14 Issue: 12
关键词: 轻度阿尔茨海默痴呆,决策,前景价态学习,体征标记假说,软件推车,记忆力减退。
摘要: Background: Alzheimer's dementia is characterized by significant cortical and subcortical atrophy, causing diverse neuropsychological deficits. According to the somatic marker hypothesis, the areas responsible for generating the somatic markers that anticipate the consequences of a decision and thereby optimize the process would be affected in these patients.
Objective: The aim of this experiment is to study the decision-making processes in Alzheimer type dementia patients to determine potential deficits in these processes as a result of the disease, aside from the cognitive impairment that is typical of aging. In addition, we wish to determine the defining characteristics of decision-making in these patients, on the basis of the prospect valence-learning parameters.
Method: We evaluated 30 patients with Alzheimer's disease and a control group of 30 healthy subjects. A short version of the Iowa Gambling Task was used.
Results: The results showed that patients made less advantageous choices than did controls. Group differences were quantitative and qualitative, as significant differences in cognitive mechanisms identified in the prospect valence-learning decisions were observed. These results are consistent with evidence from neuroimaging studies as well as with work carried out with amnesic patients.
Conclusion: That problems in our patients' decision-making could be due to the characteristic memory deficits of this disease, which prevents them from establishing new stimulus-reward relationships and eliminating previously learned responses as a result of the parietal and temporal atrophy they present.
Export Options
About this article
Cite this article as:
Cognitive Mechanisms in Decision-Making in Patients With Mild Alzheimer Disease, Current Alzheimer Research 2017; 14 (12) . https://dx.doi.org/10.2174/1567205014666170417113834
DOI https://dx.doi.org/10.2174/1567205014666170417113834 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Current Vascular Pharmacology Galanin/GALP Receptors and CNS Homeostatic Processes
CNS & Neurological Disorders - Drug Targets An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production
Mini-Reviews in Medicinal Chemistry On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?
Current Medicinal Chemistry Cerebral Ischemia and Angiogenesis
Current Neurovascular Research Heart Rate Variability Indexes in Dementia: A Systematic Review with a Quantitative Analysis
Current Alzheimer Research Small Molecules that Promote Neurogenesis in vitro
Recent Patents on CNS Drug Discovery (Discontinued) NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design The Glutathione System and its Regulation by Neurohormone Melatonin in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Memory Impairment is Associated with Serum Methylarginines in Older Adults
Current Alzheimer Research Molecular and Cellular Mechanisms for Alzheimers Disease:Understanding APP Metabolism
Current Molecular Medicine Functional Neuroimaging of Sleep Disorders
Current Pharmaceutical Design The Association and Influencing Factors between Antipsychotics Exposure and the Risk of VTE and PE: A Systematic Review and Meta-analysis
Current Drug Targets Acceptability and Results of Dementia Screening Among Older Adults in the United States
Current Alzheimer Research Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Current Alzheimer Research Diabetes-Related Neurological Implications and Pharmacogenomics
Current Pharmaceutical Design Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
Current Topics in Medicinal Chemistry